Company news: Daiichi Sankyo and GCI Health

Share this article:
Daiichi Sankyo acquired a 140,000 square foot packaging and manufacturing facility in Bethlehem Township, PA for $10 million. The facility “enables DSI to leverage existing resources to more cost-effectively supplement its operations rather than build a new facility,” said the company, which expects the plant to be operational by summer or early fall and to package products including Benicar, Welchol and Azor.

North Shore-LIJ Health System named GCI Health as its PR agency of record. The company operates 15 hospitals in New York City and Long Island.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.